Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
PUT
PPG Industries
PPG
$25B
| $9.59M | ﹤0.01% |
83,600
+67,400
| +416% | +$7.7M |
|
2352
PUT
Opko Health
OPK
$993M
| $9.59M | ﹤0.01% |
596,400
+463,100
| +347% | +$7.2M |
|
2353
Celldex Therapeutics
CLDX
$3.02B
| $9.58M | ﹤0.01% |
25,336
+4,486
| +22% | +$1.78M |
|
2354
Oshkosh
OSK
$8.82B
| $9.56M | ﹤0.01% |
225,531
+24,039
| +12% | +$1.21M |
|
2355
CALL
Carnival Corporation Ltd
CCL
$38B
| $9.55M | ﹤0.01% |
193,300
-493,500
| -72% | -$23.3M |
|
|
TMX
2356
DELISTED
Terminix Global Holdings, Inc.
TMX
| $9.54M | ﹤0.01% |
393,761
+253,630
| +181% | +$5.89M |
|
|
ALXN
2357
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $9.53M | ﹤0.01% |
52,715
-24,185
| -31% | -$4.17M |
|
|
ORAN
2358
DELISTED
Orange
ORAN
| $9.52M | ﹤0.01% |
619,564
-30,568
| -5% | -$493K |
|
2359
Agnico Eagle Mines
AEM
$75.4B
| $9.51M | ﹤0.01% |
335,306
-201,672
| -38% | -$6.26M |
|
2360
PUT
Brinker International
EAT
$9B
| $9.47M | ﹤0.01% |
+164,300
| New | +$9.4M |
|
|
SPLK
2361
CALL
DELISTED
Splunk Inc
SPLK
| $9.46M | ﹤0.01% |
135,900
+25,300
| +23% | +$1.7M |
|
2362
CALL
Bath & Body Works
BBWI
$4.02B
| $9.43M | ﹤0.01% |
136,070
+24,245
| +22% | +$1.74M |
|
2363
Direxion Daily Real Estate Bull 3X ETF
DRN
$46.5M
| $9.43M | ﹤0.01% |
611,664
+566,700
| +1,260% | +$10.5M |
|
2364
CALL
Truist Financial
TFC
$63.5B
| $9.42M | ﹤0.01% |
233,800
+78,400
| +50% | +$3.1M |
|
2365
CALL
American Eagle Outfitters
AEO
$2.9B
| $9.42M | ﹤0.01% |
547,200
+265,700
| +94% | +$4.47M |
|
2366
CALL
Smith & Nephew
SNN
$13.6B
| $9.4M | ﹤0.01% |
277,000
+177,000
| +177% | +$6.15M |
|
|
AZPN
2367
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $9.38M | ﹤0.01% |
205,871
+10,964
| +6% | +$499K |
|
|
NTK
2368
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $9.36M | ﹤0.01% |
112,535
+2,095
| +2% | +$177K |
|
2369
WPP
WPP
$4.41B
| $9.35M | ﹤0.01% |
82,917
+4,657
| +6% | +$547K |
|
2370
Ligand Pharmaceuticals
LGND
$5.94B
| $9.31M | ﹤0.01% |
147,854
-442,007
| -75% | -$24.1M |
|
|
AKS
2371
PUT
DELISTED
AK Steel Holding Corp
AKS
| $9.3M | ﹤0.01% |
2,403,400
-296,800
| -11% | -$1.47M |
|
2372
Antero Resources
AR
$10.9B
| $9.3M | ﹤0.01% |
270,697
+197,710
| +271% | +$7.85M |
|
2373
PUT
Constellation Brands
STZ
$22.3B
| $9.29M | ﹤0.01% |
80,100
+47,100
| +143% | +$5.56M |
|
2374
Groupon
GRPN
$1.06B
| $9.29M | ﹤0.01% |
92,369
+54,360
| +143% | +$7.02M |
|
|
COR
2375
DELISTED
Coresite Realty Corporation
COR
| $9.28M | ﹤0.01% |
204,238
+45,611
| +29% | +$2.18M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.